Covered recipient · General Payments record
KELLY BRITNELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,743.64
- Reported across 208 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $501.16 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $209.51 | 16 |
| Lilly USA, LLC | $158.08 | 12 |
| ABBVIE INC. | $48.94 | 3 |
| Antares Pharma, Inc. | $23.35 | 1 |
| Acerta Pharma LLC | $17.52 | 1 |
| Astellas Pharma US Inc | $15.35 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $14.38 | 1 |
| TOLMAR, INC. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.40 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106825624 | CMS |
| ABBVIE INC. | $16.88 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106825626 | CMS |
| ABBVIE INC. | $15.66 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106825628 | CMS |
| Antares Pharma, Inc. | $23.35 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146497510 | CMS |
| Astellas Pharma US Inc | $15.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139475834 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.52 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105726685 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $14.38 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153734907 | CMS |
| Lilly USA, LLC | $12.50 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771932 | CMS |
| Lilly USA, LLC | $17.97 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135759934 | CMS |
| Lilly USA, LLC | $12.51 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771934 | CMS |
| Lilly USA, LLC | $13.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735847 | CMS |
| Lilly USA, LLC | $11.29 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735849 | CMS |
| Lilly USA, LLC | $12.66 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135767575 | CMS |
| Lilly USA, LLC | $13.38 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771936 | CMS |
| Lilly USA, LLC | $18.42 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135747986 | CMS |
| Lilly USA, LLC | $11.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735851 | CMS |
| Lilly USA, LLC | $11.11 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735853 | CMS |
| Lilly USA, LLC | $11.24 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135791062 | CMS |
| Lilly USA, LLC | $11.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135759936 | CMS |
| Novo Nordisk Inc | $10.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100323696 | CMS |
| Novo Nordisk Inc | $13.88 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657824 | CMS |
| Novo Nordisk Inc | $13.77 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575822 | CMS |
| Novo Nordisk Inc | $9.30 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263132 | CMS |
| Novo Nordisk Inc | $18.01 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514909 | CMS |
| Novo Nordisk Inc | $10.40 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497177 | CMS |
| Novo Nordisk Inc | $14.46 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100551770 | CMS |
| Novo Nordisk Inc | $12.20 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378343 | CMS |
| Novo Nordisk Inc | $15.35 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381117 | CMS |
| Novo Nordisk Inc | $11.68 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100433983 | CMS |
| Novo Nordisk Inc | $12.11 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100267996 | CMS |
| Novo Nordisk Inc | $15.93 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657848 | CMS |
| Novo Nordisk Inc | $12.66 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100353752 | CMS |
| Novo Nordisk Inc | $7.40 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100227682 | CMS |
| Novo Nordisk Inc | $13.48 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583214 | CMS |
| Novo Nordisk Inc | $18.61 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100516577 | CMS |
| Tolmar, Inc. | $14.03 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138717300 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.